Exploring novel approaches to food allergy management

Area of Science:

• Immunology
• Allergy and Immunology
• Pediatric Allergy

Background:

• Food allergies (FAs) affect both pediatric and adult patients, necessitating accurate diagnosis and management.
• Current management often relies on strict dietary avoidance, impacting quality of life.
• Understanding the pathophysiology of immunoglobulin E (IgE)-mediated food allergy is crucial for developing effective treatments.

Purpose of the Study:

• To review the pathophysiology, diagnostics, and current treatments for food allergies.
• To discuss emerging and potential future treatment options for food allergies.
• To inform nurse practitioners about advancements in food allergy management.

Main Methods:

• Review of current literature on food allergy pathophysiology, diagnostics, and treatments.
• Discussion of Food and Drug Administration-approved therapies and ongoing clinical trials.
• Exploration of novel immunomodulatory treatments, including biologic agents.

Main Results:

• Oral immunotherapy (OIT) is FDA-approved for peanut allergy, with trials exploring multi-allergen OIT and alternative administration routes.
• Biologic agents such as omalizumab, dupilumab, and etokimab are under investigation for food allergy treatment.
• These novel therapies offer hope for improved management beyond strict avoidance.

Conclusions:

• Advancements in food allergy research provide new therapeutic avenues.
• Nurse practitioners play a vital role in educating patients about and facilitating shared decision-making for novel treatment options.
• The future of food allergy management includes personalized treatment strategies and improved patient outcomes.